Key facts
- Notable investors include Changda Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Mingli Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Mingli Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mingli Medical
Developer of diagnostic and data-driven medical technologies designed for clinical pathology and healthcare digitization. The company's platform integrates AI-assisted diagnostic software, cloud-based pathology services, structured reporting tools, and quality control systems, enabling hospitals and laboratories in China to enhance diagnostic accuracy, streamline pathology workflows, support sub-specialty training, and accelerate the digital transformation of medical diagnostics.
- Sector
- Healthcare
- HQ
- Wuhan, China
- Founded
- 2018
- Employees
- 20
- Ownership
- Privately Held (backing)
Mingli Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mingli Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mingli Medical in its N-PORT filings yet. We sweep new filings monthly.